
MiMedx Group, Inc.
MDXGHealthcare|Biotechnology|US
$3.31
+0.03 (+0.91%)
DCF Value
$3.75
Tangible Book / Share
$1.24
Cash / Share
$0.83
Next Earnings Report
Feb 24, 2027
EPS est. $0.02 · Revenue est. $68.5M
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Sep 4, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (1)
Jan 2027
Est. completion
NADiabetic Foot Ulcer
Post-Marketing Surveillance of Dehydrated Human Amnion/Chorion Membrane (DHACM) in Non-Ischemic Chronic Wounds
NCT06236750n=75
Recent Press Releases
MIMEDX to Participate in Upcoming Investor Conferences
Nov 6, 2026 · GlobeNewsWire
MIMEDX Announces Third Quarter 2026 Operating & Financial Results
Oct 28, 2026 · GlobeNewsWire
MIMEDX Announces $25 Million Patent License Agreement
Oct 28, 2026 · GlobeNewsWire
MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026
Oct 14, 2026 · GlobeNewsWire
MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter
Sep 23, 2026 · GlobeNewsWire
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
Sep 10, 2026 · Business Wire
MIMEDX to Participate in Upcoming Investor Conferences
Sep 8, 2026 · GlobeNewsWire
SEC Filings (50)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 28, 2026 | 425 | DocumentIndex | |
| Oct 28, 2026 | 8-K | Material event | DocumentIndex |
| Oct 28, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Oct 16, 2026 | 425 | DocumentIndex | |
| Oct 16, 2026 | 8-K | Material event | DocumentIndex |
| Sep 4, 2026 | EFFECT | DocumentIndex | |
| Sep 4, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Aug 25, 2026 | S-4 | DocumentIndex | |
| Aug 11, 2026 | 425 | DocumentIndex | |
| Aug 11, 2026 | 8-K/A | Material event | DocumentIndex |
| Jul 30, 2026 | 425 | DocumentIndex | |
| Jul 30, 2026 | 425 | DocumentIndex | |
| Jul 29, 2026 | 425 | DocumentIndex | |
| Jul 29, 2026 | 425 | DocumentIndex | |
| Jul 29, 2026 | 425 | DocumentIndex | |
| Jul 29, 2026 | 8-K | Material event | DocumentIndex |
| Jul 29, 2026 | 425 | DocumentIndex | |
| Jul 29, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 29, 2026 | 8-K | Material event | DocumentIndex |
| Jun 16, 2026 | 8-K | Material event | DocumentIndex |
| Apr 29, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 29, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 29, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 29, 2026 | 8-K | Material event | DocumentIndex |
| Apr 29, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 16, 2026 | 8-K | Material event | DocumentIndex |
| Feb 25, 2026 | 8-K | Material event | DocumentIndex |
| Feb 25, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 12, 2026 | 8-K | Material event | DocumentIndex |
| Oct 29, 2025 | 8-K | Material event | DocumentIndex |
| Oct 29, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Sep 3, 2025 | 8-K | Material event | DocumentIndex |
| Jul 30, 2025 | 8-K | Material event | DocumentIndex |
| Jul 30, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Jul 28, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Jun 20, 2025 | 8-K | Material event | DocumentIndex |
| May 23, 2025 | ARS | Annual report to holders | DocumentIndex |
| May 23, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| May 13, 2025 | 8-K | Material event | DocumentIndex |